Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Exercise adherence in a randomized trial of exercise on aromatase inhibitor arthralgias in breast cancer survivors: the Hormones and Physical Exercise (HOPE) study

Exercise adherence in a randomized trial of exercise on aromatase inhibitor arthralgias in breast... J Cancer Surviv (2016) 10:654–662 DOI 10.1007/s11764-015-0511-6 Exercise adherence in a randomized trial of exercise on aromatase inhibitor arthralgias in breast cancer survivors: the Hormones and Physical Exercise (HOPE) study 1 2 2,3 2 2 Hannah Arem & Mia Sorkin & Brenda Cartmel & Martha Fiellin & Scott Capozza & 2 2,3 3 3 3 Maura Harrigan & Elizabeth Ercolano & Yang Zhou & Tara Sanft & Cary Gross & 4 5 6 7 Kathryn Schmitz & Tuhina Neogi & Dawn Hershman & Jennifer Ligibel & 2,3,8 Melinda L. Irwin Received: 30 June 2015 /Accepted: 25 December 2015 /Published online: 19 January 2016 Springer Science+Business Media New York 2016 Abstract medical characteristics and used the t test for mean differ- Purpose Up to 50 % of postmenopausal breast cancer survi- ences. We also examined predictors of adherence using linear vors taking aromatase inhibitors (AIs) experience AI- regression. associated arthralgias, or joint pain, which causes many to Results On average, at the end of the year long trial, women stop taking AIs and may inhibit exercise, despite known reported 119 (SD 78) min/week of moderate-intensity aerobic health benefits. We thus evaluated exercise adherence and exercise and participated in 70 % http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Journal of Cancer Survivorship: Research and Practice Springer Journals

Exercise adherence in a randomized trial of exercise on aromatase inhibitor arthralgias in breast cancer survivors: the Hormones and Physical Exercise (HOPE) study

Download PDF
9 pages

Loading next page...
 
/lp/springer-journals/exercise-adherence-in-a-randomized-trial-of-exercise-on-aromatase-7iRSSCq7U1

References (25)

Publisher
Springer Journals
Copyright
Copyright © 2016 by Springer Science+Business Media New York
Subject
Medicine & Public Health; Public Health; Oncology; Health Promotion and Disease Prevention; Health Informatics; Quality of Life Research; Primary Care Medicine
ISSN
1932-2259
eISSN
1932-2267
DOI
10.1007/s11764-015-0511-6
pmid
26782031
Publisher site
See Article on Publisher Site

Abstract

J Cancer Surviv (2016) 10:654–662 DOI 10.1007/s11764-015-0511-6 Exercise adherence in a randomized trial of exercise on aromatase inhibitor arthralgias in breast cancer survivors: the Hormones and Physical Exercise (HOPE) study 1 2 2,3 2 2 Hannah Arem & Mia Sorkin & Brenda Cartmel & Martha Fiellin & Scott Capozza & 2 2,3 3 3 3 Maura Harrigan & Elizabeth Ercolano & Yang Zhou & Tara Sanft & Cary Gross & 4 5 6 7 Kathryn Schmitz & Tuhina Neogi & Dawn Hershman & Jennifer Ligibel & 2,3,8 Melinda L. Irwin Received: 30 June 2015 /Accepted: 25 December 2015 /Published online: 19 January 2016 Springer Science+Business Media New York 2016 Abstract medical characteristics and used the t test for mean differ- Purpose Up to 50 % of postmenopausal breast cancer survi- ences. We also examined predictors of adherence using linear vors taking aromatase inhibitors (AIs) experience AI- regression. associated arthralgias, or joint pain, which causes many to Results On average, at the end of the year long trial, women stop taking AIs and may inhibit exercise, despite known reported 119 (SD 78) min/week of moderate-intensity aerobic health benefits. We thus evaluated exercise adherence and exercise and participated in 70 %

Journal

Journal of Cancer Survivorship: Research and Practice – Springer Journals

Published: Jan 19, 2016

There are no references for this article.